Trademark: 97725228
Word
KERFREYA
Status
Registered
Status Code
700
Status Date
Tuesday, January 16, 2024
Serial Number
97725228
Registration Number
7276576
Registration Date
Tuesday, January 16, 2024
Mark Type
4000
Filing Date
Tuesday, December 20, 2022
Published for Opposition
Tuesday, October 31, 2023

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Jan 22, 2024
Notice Of Registration Confirmation Emailed
Jan 16, 2024
Notice Of Registration Confirmation Emailed
Jan 16, 2024
Notice Of Registration Confirmation Emailed
Jan 16, 2024
Registered-Principal Register
Oct 31, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 31, 2023
Published For Opposition
Oct 11, 2023
Notification Of Notice Of Publication E-Mailed
Sep 21, 2023
Approved For Pub - Principal Register
Sep 19, 2023
Assigned To Examiner
Jul 12, 2023
Teas Change Of Correspondence Received
Jul 12, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 12, 2023
Teas Change Of Owner Address Received
Jan 17, 2023
New Application Office Supplied Data Entered
Dec 23, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24